Host: |
Mouse |
Applications: |
FC |
Reactivity: |
Human |
Note: |
FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Endoglin is suitable for use in Flow Cytometry research applications. |
Clonality: |
Monoclonal |
Clone ID: |
SN6 |
Conjugation: |
EF488 |
Isotype: |
IgG1k |
Formulation: |
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
Purification: |
Affinity purified |
Concentration: |
5 Mu L/Test |
Storage Instruction: |
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
Tissue Specificity | Detected on umbilical veil endothelial cells. Detected in placenta (at protein level). Detected on endothelial cells. |
Function | Vascular endothelium glycoprotein that plays an important role in the regulation of angiogenesis. Required for normal structure and integrity of adult vasculature. Regulates the migration of vascular endothelial cells. Required for normal extraembryonic angiogenesis and for embryonic heart development. May regulate endothelial cell shape changes in response to blood flow, which drive vascular remodeling and establishment of normal vascular morphology during angiogenesis. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors. Acts as a TGF-beta coreceptor and is involved in the TGF-beta/BMP signaling cascade that ultimately leads to the activation of SMAD transcription factors. Required for GDF2/BMP9 signaling through SMAD1 in endothelial cells and modulates TGFB1 signaling through SMAD3. |
Protein Name | EndoglinCd Antigen Cd105 |
Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Endoglin antibodyAnti-Cd Antigen Cd105 antibodyAnti-ENG antibodyAnti-END antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance